Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cel-Sci
Biotech
FDA request extends CEL-SCI's multidecade Multikine journey
CEL-SCI will need another clinical trial for its Multikine cancer drug—which the company has long trumpeted as a promising therapy despite shaky data.
Annalee Armstrong
Jul 14, 2023 10:32am
Cel-Sci CEO tries to spin cancer trial failure into an FDA win
Jul 7, 2021 3:40pm
Cel-Sci cancer phase 3 misses primary endpoint, sinking stock
Jun 29, 2021 8:45am
Embattled Cel-Sci to tackle COVID-19 with immunotherapy tech
Mar 24, 2020 7:55am
Cel-Sci CEO paints 'promising future' in letter to shareholders
Aug 22, 2018 8:09am
Cel-Sci wins 4.5-year-long arbitration case against CRO
Jul 10, 2018 4:18pm